Dhanuka Agritech Profit Soars 30% in Q4 FY26, Board OKs Share Buyback

AGRICULTURE
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
Dhanuka Agritech Profit Soars 30% in Q4 FY26, Board OKs Share Buyback
Overview

Dhanuka Agritech reported a 30% rise in Q4 FY26 profit to Rs 97.77 crore, driven by a 9% revenue increase to Rs 483.34 crore. The company's board also recommended a 100% dividend and approved a share buyback program.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Dhanuka Agritech Reports Strong Q4 FY26 Earnings and Approves Shareholder Returns

Dhanuka Agritech announced a significant 30% year-on-year jump in its profit after tax for the fourth quarter of fiscal year 2026, reaching Rs 97.77 crore. This strong performance followed a 9% increase in revenue, which climbed to Rs 483.34 crore from Rs 442.02 crore in the same quarter last year. Earnings before interest, taxes, depreciation, and amortization (EBITDA) also showed healthy growth, rising to Rs 124.89 crore from Rs 109.75 crore.

Key Financial Highlights

Dhanuka Agritech's financial results for the fourth quarter and the full fiscal year 2026 revealed robust profit growth. The company reported a strong 30% year-on-year increase in net profit for the quarter. In addition to the financial results, the board of directors proposed a dividend of 100% and greenlit a share buyback plan to repurchase up to 5 lakh equity shares at a maximum price of Rs 1,400 per share. An Employee Stock Option Plan (ESOP) was also approved by the board.

Significance of the Announcements

The combination of substantial profit growth, a proposed dividend payout, and an approved share buyback highlights Dhanuka Agritech's solid financial standing and the management's confidence in the company's future performance. The share buyback, set at a price above the current market rate, provides a direct benefit to shareholders. This improved profitability indicates effective cost management and a favorable shift in the company's product mix.

Industry Context

Dhanuka Agritech operates within the agricultural sector, an industry closely linked to weather patterns and broader economic conditions. The company has faced challenging operating conditions in recent quarters due to unpredictable weather, issues with channel liquidity, and global economic uncertainties. Despite these obstacles, Dhanuka Agritech has successfully maintained its growth trajectory.

Strategic Moves and Future Integration

The authorized share buyback program will enable the company to reacquire its own shares, potentially leading to an increase in earnings per share. The new ESOP plan is designed to attract and retain crucial talent within the organization. Furthermore, Dhanuka Agritech is in the process of integrating products acquired from Bayer, which are anticipated to contribute significantly to future revenue streams.

Potential Risks and Challenges

Investors should remain aware of the ongoing risks, including the volatile operating environment marked by erratic weather, fluctuating crop economics, and global instability. The near-term demand for the company's products is closely dependent on the monsoon season's performance. An increase in input costs, if not effectively passed on to consumers, could also impact profit margins. The company also recently canceled a memorandum of understanding with a Spanish firm due to concerns over the agreement's terms.

Performance Metrics

  • Q4 FY26 Revenue: Rs. 483.34 crore (compared to Rs. 442.02 crore in Q4 FY25)
  • Q4 FY26 EBITDA: Rs. 124.89 crore (compared to Rs. 109.75 crore in Q4 FY25)
  • Q4 FY26 Profit After Tax: Rs. 97.77 crore (compared to Rs. 75.50 crore in Q4 FY25)
  • Full year GST refund received: Rs. 29 crore (Rs. 14.5 crore recognized in Q4 FY26)
  • Dahej plant sales in FY26: Rs. 50 crore (up from Rs. 41 crore in the prior year)
  • Dahej plant EBITDA loss in FY26: Rs. 13 crore (reduced from Rs. 14 crore in the prior year)
  • Revenue from Bayer products in FY26: Rs. 27 crore
  • Biostimulant and biological portfolio sales in FY26: Rs. 70 crore (compared to Rs. 110 crore in FY25)
  • Full year royalty payment: Rs. 32 crore (Rs. 10 crore paid in Q4 FY26)

What to Monitor Next

Looking ahead, investors will closely track Dhanuka Agritech's capacity to manage the prevailing challenging market conditions. Key focus areas include the successful integration of Bayer's product portfolio into its offerings and anticipated revenue growth from its biostimulant products in fiscal year 2027. The company's ability to adjust pricing to offset any rises in input costs will also be critical for maintaining profitability.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.